STOCK TITAN

Medigus Ltd. - $MDGS STOCK NEWS

Welcome to our dedicated page for Medigus Ltd. news (Ticker: $MDGS), a resource for investors and traders seeking the latest updates and insights on Medigus Ltd. stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Medigus Ltd.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Medigus Ltd.'s position in the market.

Rhea-AI Summary

Xylo Technologies announced that its 19.99% owned subsidiary, Metagramm Software, completed the development of Bubbl, an advanced AI-powered writing tool. Bubbl employs Machine Learning, Natural Language Processing, and Deep Learning to offer personalized text writing and rewriting, setting it apart from other AI tools. The tool features a clean design and various user modes, including interactive re-write and grammar-only modes. It supports multiple writing profiles, such as Business, Medical, Academic, and Blogging, each with tailored assistance. Bubbl will launch for select users in Q3 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
AI
-
Rhea-AI Summary

Xylo Technologies (Nasdaq: XYLO) has signed a letter of intent (LOI) to acquire a leading AI technology company based in Germany. This acquisition aims to expand Xylo's portfolio into advanced AI technologies such as predictive maintenance and condition monitoring. The target company has been a European leader for over a decade, providing AI and machine learning solutions to various global industries including aerospace, aviation, transportation, real estate, and security. Xylo will make a down payment of 1.5 million Euros and initially acquire 51% of the target company's shares, with the remaining 49% contingent on the company's 2024 EBITDA results. This strategic move was facilitated by Xylo's newly appointed senior advisor, an expert in AI with a distinguished career in both academia and industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.9%
Tags
-
Rhea-AI Summary

Xylo Technologies (Nasdaq: XYLO) announced that Charging Robotics (OTC: FDOCD), 67% owned by Xylo, in collaboration with Make My Day, has reached the final development stage of an AI-based EV charging management system.

This system addresses the challenge of insufficient electricity supply for EV charging in automatic car parks by using machine learning algorithms to prioritize and optimize charging sequences based on parameters such as departure time, vehicle type, and driving style.

The system integrates seamlessly with Charging Robotics’ wireless charging setup and was recently piloted in Tel Aviv, Israel.

CEO Hovav Gilan emphasized the value this feature adds for future customers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.88%
Tags
AI
Rhea-AI Summary
Xylo Technologies, formerly known as Medigus , has filed its 2023 Annual Report on Form 20-F, including audited financial statements for the year ended December 31, 2023. The report is available on the company's investor relations website and the SEC's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.96%
Tags
none
-
Rhea-AI Summary
Medigus (NASDAQ: MDGS) announced a corporate rebranding to Xylo Technologies with a new trading symbol XYLO on April 18, 2024. The rebranding signifies the Company's focus on innovation technologies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.41%
Tags
none
-
Rhea-AI Summary
Medigus announces a milestone achievement by its subsidiary, Charging Robotics , in successfully installing a wireless charging system for an automatic parking system, a first in the industry. The system, reaching a power of 10kW, aims to address the challenge of charging electric vehicles in automatic car parks by utilizing wireless technology. The innovative solution allows for efficient charging without the need for manual cable connections, enhancing the convenience for EV owners.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.36%
Tags
none
Rhea-AI Summary
Medigus (Nasdaq: MDGS) announces the completion of the initial production batch of 50 units of its micro-mobility electric vehicle 'PORTO' by its EV joint venture Revoltz The joint venture aims to sell 150 vehicles in the first year under a $2.7 million revenue Agreement with a premier distributor in Israel. The PORTO EV offers a 100 km range, 250L delivery payload, and advanced stability features, tailored for the last-mile delivery market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.1%
Tags
none
-
Rhea-AI Summary
Medigus (Nasdaq: MDGS) subsidiary, Charging Robotics , successfully installs wireless charging system for automatic car parks in Tel Aviv, Israel. The system reaches a charging power of 10kW, includes managed charging capabilities, and a user interface on the driver's smartphone. This innovative solution aims to address the challenge of charging electric vehicles parked in automatic car parks, where traditional cables are impractical. Charging Robotics collaborated with Make My Day for the system's user interface.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.04%
Tags
none
-
Rhea-AI Summary
Medigus Ltd. (Nasdaq: MDGS) announces the expansion of collaboration between ParaZero Technologies Ltd. and Vayu Aerospace Corporation to integrate safety systems into Vayu's fleet of delivery drones. The global VTOL unmanned aerial vehicles market is projected to reach $27.5 Billion by 2030, with a CAGR of 19.9% between 2022 and 2030.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
partnership
Rhea-AI Summary
Medigus Ltd. (Nasdaq: MDGS) announces the pre-order launch of PORTO, an innovative electric vehicle (EV) from its subsidiary, Revoltz Ltd. The pre-order launch is led by Revoltz Ltd., a company specializing in high-end, mini electric vehicles, bringing innovation and elevating single-rider transportation. The PORTO is designed for modern cities, combining long-range capability, robust design, and exceptional agility, marking a significant step in Revoltz's commitment to sustainable, efficient, and cutting-edge urban logistics solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.57%
Tags
none
Medigus Ltd.

Nasdaq:MDGS

MDGS Rankings

MDGS Stock Data

4.47M
25.52M
0.29%
0.22%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Pob 3030

About MDGS

medical device company focused on innovative endoscopic procedures and devices. medigus developed an entire endoscopic system for intraluminal treatment of gerd (gastroesophageal reflux disease), one of the most common chronic diseases in the western world. the endoscopic system for the treatment of gerd - the srs - combines a miniaturized video camera, a surgical stapler and ultrasonic sights for alignment in a single instrument. the srs system and its unique flexible endoscope allows gastroenterologists and surgeons to perform endoluminally a true partial anterior fundoplication, thereby revolutionizing the treatment of gerd by eliminating the need for open or laparoscopic surgery - the current standard practice for treating severe gerd. shifting the gerd treatment from surgery to an endoluminal procedure, without opening the abdominal cavity, is a revolution. in addition, medigus designs and manufactures endoscopy systems for partner companies based on its proprietary technologies,